To date, there is no known cure for Alzheimer's Disease. Current drug treatments offer modest symptom relief, but none of the medications is known to delay or halt the progression of the disease.

McGill and the Douglas have joined hands to create the StoP-AD Centre dedicated to the prevention of AD.

Alzheimer's disease: A ticking bomb Canada and the world face a ruinous increase in the incidence of dementia caused by Alzheimer’s disease (AD). Around the globe, more than 35 million people have dementia. Their care costs $600 billion each ye

Most anxiety disorders are treated with cognitive-behavioral therapy (CBT), medication, or a combination of the two.

Neurocognitive studies by the McGill Group of Suicide Studies (MGSS) attempt to understand the link between the brain on one hand; and thoughts, emotions and behaviour on the other.

The Medical Records Department is responsible for protecting personal information and preserving patient charts.

Martin Lepage's team is working on the following neurocognitive and neuroimaging research projects.

StoP-AD Centre has established graduate student and post-doctoral training scholarships.

Team members of the Martin Lepage Laboratory

Between head and heart > Mini-Psych School 2011 classes now available online. A video will be published every week.